Founder and CEO of US online social media and social networking service Facebook Mark Zuckerberg. Photo by KENZO TRIBOUILLARD/AFP via Getty Images/FILE)
Mark Zuckerberg and his wife Priscilla Chan have donated $25 million through their foundation to a philanthropic effort organized by Bill Gates to explore new coronavirus treatments.
The Gates Foundation donated $50 million last week to what it’s calling the “COVID-19 Therapeutics Accelerator.” The initiative brings together life sciences companies to collaborate on the development of new vaccines, diagnostics, and treatments for COVID-19.
“The Therapeutics Accelerator will enable researchers to quickly determine whether or not existing drugs have a potential benefit against COVID-19,” Chan and Zuckerberg said in a press release. “We hope these coordinated efforts will help stop the spread of COVID-19 as well as provide shared, reusable strategies to respond to future pandemics.”
The two donations are the largest from tech billionaires since the coronavirus outbreak. Wellcome and Mastercard are supporting the effort as well.
The goal of the initiative is to either develop a new drug or adapt an existing treatment that it could help distribute alongside partnering pharmaceutical companies.
The 15 companies participating in the project kicked off the effort by sharing their proprietary libraries of molecular compounds that have some history of being tested with COVID-19.
The lineup includes big names in biotech such as Johnson & Johnson, Merck, Pfizer, Sanofi, and Bristol-Myers Squibb.
A NASA spacecraft that will deliberately crash into an asteroid is preparing to launch this week. The goal of the DART mission, or the Double Asteroid Redirection Test, is to hit the smaller of the two asteroids, Dimorphos, with the spacecraft at about 15,000 miles per hour and see how the impact changes the asteroid’s trajectory. Joey Roulette, space reporter at The New York Times, joins Cheddar News to talk more about it.
On this episode of Cheddar Reveals, Yair Nechmad, Nayax CEO, discusses the future of cashless payments, and how cashless payments give retailers a competitive edge and allow merchants to scale business; Jason Thomas, Global CEO of Tappit, breaks down how the pandemic accelerated the transition to cash-free live events, and why that trend is here to stay; Cheddar gets a look at Curiosity Steam's 'Blockchain Revolution.'
Not long ago, banning cash at a large public event would have been seen as a crazy idea that would deter sales. But our cash-free future is getting closer with the use of contactless payments being implemented in sports venues, music festivals, concerts, and more. Jason Thomas, Global CEO of Tappit, joins Cheddar Reveals to break down how the pandemic accelerated the transition to cash-free live events, and why that trend is here to stay.
Yair Nechmad, Nayax CEO, joins Cheddar Reveals to discuss the future of cashless payments, and how cashless payments give retailers a competitive edge and allow merchants to scale business.
Bentley aims to become end-to-end carbon neutral by 2030. The luxury car brand has outlined steps to achieve this goal, including switching its entire model range to plug-in hybrid or battery electric vehicles by 2026 and become fully electric by 2030. Christophe Georges, president & CEO of Bentley Americas, joined Cheddar to discuss this new pledge and what consumers can expect from future models.
ORIGYN Foundation, an NFT authentication start-up based in Switzerland, has secured $20 million in funding from investors like Paris Hilton, Bill Ackman, and Polychain Capital, among others. The non-profit, now valued at $300 million, uses AI technology to verify non-fungible tokens across art, collectibles, digital media and luxury goods. Daniel Haudenschild, CEO of ORIGYN Entreprise, discusses how the money will help put power back into the hands of artists, creators, and collectors.
Michael S. Weinstein, chair of the white collar criminal defense practice at Cole Schotz, joined "Wake Up With Cheddar" to break down the defense's strategy to put Elizabeth Holmes on the stand in the former Theranos CEO's criminal fraud trial. "She's humanizing herself, and she's certainly coming off as they would want her to," he said. "I think what really is going to be interesting and really where the rubber meets the road is when the cross-examination commences, and they're able to pick apart her story and contrast what she's currently saying to what she previously said on multiple occasions in the last five to seven years."
